PHF5A and non-small cell lung carcinoma: Recently, when using gene expression levels calculated from TCGA LUAD and LUSC level 3 RNA–seq data, PHF5A was found to be significantly negatively–associated with patient OS in LUAD.24 Therefore, we verified the associations between PHF5A expression and NSCLC patient survival using data sets provided by the Kaplan‐Meier plotter.25 Higher PHF5A mRNA expression was significantly correlated with shorter OS in LUAD patients (n = 673) (Figure 1D) but not in LUSC patients (n = 271) (Figure 1E).